Clinical Efficacy and Safety of Eight Traditional Chinese Medicine Combined with Entecavir in the Treatment of Chronic Hepatitis B Liver Fibrosis in Adults: A Network Meta-Analysis

<div>(a) The HA of TCM plus entecavir versus entecavir. (b) The LN of TCM plus entecavir versus entecavir. (c) The PCIII of TCM plus entecavir versus entecavir. (d) The IV-C of TCM plus entecavir versus entecavir. <i>I</i><sup>2</sup> and <i>P</i> are the criterion for the heterogeneity test, ◆ pooled odds ratio, —■— odds ratio, and 95% CI.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Clinical Efficacy and Safety of Eight Traditional Chinese Medicine Combined with Entecavir in the Treatment of Chronic Hepatitis B Liver Fibrosis in Adults: A Network Meta-Analysis 

Figure 2 | Clinical Efficacy and Safety of Eight Traditional Chinese Medicine Combined with Entecavir in the Treatment of Chronic Hepatitis B Liver Fibrosis in Adults: A Network Meta-Analysis 